
NYSEHealthcareMedical - Instruments & Supplies
最新数据
US$15.67
+US$0.28 · +1.82%
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
前收盘价
US$15.67
+US$0.28 · +1.82%
盘前
US$15.74
+US$0.07 · +0.45%
10月12日 4:27 ET
盘中时间采用ET。市场数据可能有所延迟。
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
日内区间
当前US$15.67
52周区间
当前US$15.67
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
20
估值过高
情绪
54
多空交织
风险
53
风险偏高
动量
51
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
日内区间
当前US$15.67
52周区间
当前US$15.67
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 65.52亿 USD | 67.84亿 USD | 69.67亿 USD | 75.12亿 USD | 73.86亿 USD |
| 销货成本 | 44.13亿 USD | 45.04亿 USD | 46.03亿 USD | 49.1亿 USD | 48.83亿 USD |
| 毛利 | 21.39亿 USD | 22.79亿 USD | 23.64亿 USD | 26.03亿 USD | 25.03亿 USD |
| 销售、一般及管理费用 | 15.96亿 USD | 16.41亿 USD | 15.07亿 USD | 14.73亿 USD | 15.31亿 USD |
| 营业费用 | 23.86亿 USD | 11.95亿 USD | 16.67亿 USD | 14.73亿 USD | 15.31亿 USD |
| 利息支出 | 1.7亿 USD | 2.19亿 USD | 2.85亿 USD | 2.66亿 USD | 2.17亿 USD |
| 折旧和摊销 | 4.1亿 USD | 4.06亿 USD | 4.02亿 USD | 4.06亿 USD | 3.79亿 USD |
| 营业利润 | −2.46亿 USD | 10.85亿 USD | 6.96亿 USD | 11.3亿 USD | 9.72亿 USD |
| 净利润 | −5.3亿 USD | 7.12亿 USD | 3.21亿 USD | 6.87亿 USD | 5.73亿 USD |
公司数据更新于 2026年10月12日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$11.67
下跌空间 25.53%价格历史记录不可用
最高:US$16.00平均的:US$11.67最低:US$7.00AI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。